WANDA BEARING
920002
WINDA
873001
SANWEI CO.,LTD.
831834
4
SUZHOUBEARING
430418
5
Fujian Yuanxiang New Materials
301300
US Stock MarketDetailed Quotes
XTLB XTL Biopharmaceuticals
- 1.520
- -0.030-1.94%
Close Feb 19 16:00 ET
- 1.520
- 0.0000.00%
Post 20:01 ET
13.40MMarket Cap-7.60P/E (TTM)
1.640High1.500Low1.20KVolume1.640Open1.550Pre Close1.83KTurnover0.02%Turnover RatioLossP/E (Static)8.81MShares4.99052wk High2.34P/B11.40MFloat Cap0.76852wk Low--Dividend TTM7.50MShs Float600.000Historical High--Div YieldTTM9.03%Amplitude0.625Historical Low1.531Avg Price1Lot Size
XTL Biopharmaceuticals News
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Trending Stocks
Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1
Moo Live
Feb 12 16:30
Alibaba Group Q4 FY2024 earnings conference call